Beyond Air is a medical device and biopharmaceutical company developing a nitric oxide (NO) generator and delivery system (the LungFit system) that is capable of generating NO from ambient air. The LungFit system can deliver NO either continuously or for a fixed amount of time at various flow rates and has the ability to either titrate dose on demand or maintain a constant dose. Co.'s initial areas of focus with the LungFit are persistent pulmonary hypertension of the newborn, severe acute respiratory syndrome coronavirus 2, bronchiolitis and nontuberculous mycobacteria. An additional focus of Co. is solid tumors. The XAIR stock yearly return is shown above.
The yearly return on the XAIR stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2021 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the XAIR annual return calculation with any dividends reinvested as applicable (on ex-dates).
|